The frequency of yeast-like fungal colonization of the oral mucosa in patients with Sjögren’s syndrome constitutes 40.0 ± 1.63%. Fungi are detected on the mucous membrane of the tongue more often (36.7 ± 1.61%) than on the mucous membrane of the gums (23.3 ± 1.41%). The extent of tongue mucosa colonization is also higher in comparison with the gum colonization. The extent of Candida colonization of tongue mucosa is 2.5 times higher in women with Sjögren’s syndrome as compared to men.
The objective of the research was to study the level of candida colonization of various oral mucosa areas in patients with Sjögren’s syndrome.
26 fungal cultures were isolated from the examined patients. Candida albicans predominated among them constituting 14 strains (53.8±1.92%). C. albicans colonization of the oral mucosa was detected in 10 patients with Sjögren’s syndrome (30.0±1.53%). The extent of tongue mucosa colonization was 3.95±1.32 lg CFU/ml and the extent of gum colonization constituted 3.08±0.60 lg CFU/ml.
Mykhailenko TM, Kutsyk RV, Rozhko MM. Sposib zaboru materialu dlia diahnostyky mikrobnoho biotsenozu rotovoii porozhnyny u osib iz znimnymy protezamy. Ukrainian patent UA 26076. 2007 September 10.
Abraham CM, al-Hashimi I, Haghighat N. Evaluation of the levels of oral Candida in patients with Sjögren's syndrome. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.1998;86(1):65-68. doi: doi.org/10.1016/S1079-2104(98)90151-2 DOI: https://doi.org/10.1016/S1079-2104(98)90151-2
Almstahl A, Wikström M, Kroneld U. Microflora in oral ecosystems in primary Sjögren's syndrome. J. Rheumatol. 2001;28(5):1007-1013. [PMid:11361180]
Ding N, Yan ZM, Hua H. Detection of oral fungal flora in patients with primary Sjogren's syndrome by real-time PCR. Beijing Da Xue Xue Bao (J. Peking Univ. Health Sci. 2013;45(1):17-21.
Ergun S, Çekici A, Topcuoglu N et al. Oral status and Candida colonization in patients with Sjögren's syndrome. Med. Oral Patol. Oral Cir. Bucal. 2010;15(2):e310- e315. DOI: https://doi.org/10.4317/medoral.15.e310
Fox RI. Sjögren's syndrome: Evolving therapies. Expert Opin. Investig. Drugs. 2003;12:247-254. doi: doi.org/10.1517/13543722.214.171.124. DOI: https://doi.org/10.1517/135437126.96.36.199
Hernandez YL, Daniels TE. Oral candidiasis in Sjögren's syndrome: Prevalence, clinical correlations, and treatment. Oral Surg. Oral Med. Oral Pathol. 1989;68(3):324-329. DOI: https://doi.org/10.1016/0030-4220(89)90218-1
Houang ETS, Chu KC, Koehler AP, Cheng AFB. Use of CHROMagar Candida for genital specimens in the diagnostic laboratory. J. Clin. Pathol. 1997;50(7):563-565. DOI: https://doi.org/10.1136/jcp.50.7.563 [PMid:9306935 PMCid:PMC500052]
Kindelan SA, Yeoman CM, Douglas CWI, et al. A comparison of intraoral Candida carriage in Sjögren's syndrome patients with healthy xerostomic controls. Oral Surg. Oral Med. Oral Pathol. 1998;85(2):162-167. doi: doi.org/10.1016/S1079-2104(98)90420-6. DOI: https://doi.org/10.1016/S1079-2104(98)90420-6
Leung KCM, McMillan AS, Cheung BPK, Leung WK. Sjögren's syndrome sufferers have increased oral yeast levels despite regular dental care. Oral Diseases. 2008;14:163-173. DOI: https://doi.org/10.1111/j.1601-0825.2007.01368.x
Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 1994;32(8):1923-1929. [PMid:7989544 PMCid:PMC263904]
Radfar L, Shea Y, Fischer SH et al. Fungal load and candidiasis in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96(3):283-287. DOI: https://doi.org/10.1016/S1079-2104(03)00224-5
Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. A comparison of three methods for detecting Candida albicans in patients with Sjögren's syndrome. Quintessence Int. 1998;29(2):107-113. [PMid:9643244]
Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren's syndrome. J. Otolaryngol. 1997;26(5):300-305. [PMid:9343767]
Yan Z, Young AL, Hua H, Xu Y. Multiple oral Candida infections in patients with Sjogren's syndrome – prevalence and clinical and drug susceptibility profiles. J. Rheumatol. 2011;38(11):2428-2431. DOI: https://doi.org/10.3899/jrheum.100819
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.